WHAT THIS PAPER ADDS This is the first study examining UPR-activation in human rupture-prone carotid plaques, and the proapoptotic UPR-CHOP signaling pathway was identified as a potential inducer of apoptosis in vascular cells. On the basis of these results, acute cerebrovascular events (stroke and TIA) are now joined with acute coronary syndromes as clinical events that warrant intense research into development and implementation of anti-apoptotic strategies, including targeting activation of the UPR-PERK/CHOP-branch specifically. That, in turn, may relieve ER-stressinduced apoptosis and thereby has the potential to reduce plaque progression/ruptures in cardiovascular disease.
INTRODUCTION
Plaque rupture is the most common cause of coronary artery thrombosis and serves as the pathomorphological correlate for acute coronary syndrome. 1 In the cerebrovascular circulation, plaque rupture of carotid lesions has been identified as being positively associated with recent TIA (transitory ischemic attack) and stroke. 2, 3 Atherosclerosis as the underlying disease is a progressive inflammatory process triggered by retention of lipids in the arterial wall, 4 leading to multifocal lesion development and formation of vulnerable plaques, the precursor of plaque rupture, being characterized by a large necrotic core (>30% of plaque) and a thin fibrous cap (<65 mm). 5 Increased apoptosis of lesional macrophages is one of the molecular mechanisms that leads to increased size of the necrotic core and thinning of the fibrous cap. 6 Among several triggers of apoptosis, ER (endoplasmic reticulum)stress was identified as a potent inducer of macrophage apoptosis. 7 c B. Dorweiler and I. Grechowa contributed equally to this work. ER-stress occurs as a consequence of a mismatch between the load of unfolded and misfolded proteins in the ER and the capacity of the cellular machinery that copes with that load and sets a compensatory mechanism, the unfolded protein response (UPR), in motion, which reduces protein load and increases folding capacity. If cellular homeostasis cannot be re-established, programmed cell death (apoptosis) is initiated. 8 This is achieved by phosphorylation of the ER-membrane bound protein kinase RNA-like ER kinase (PERK), which, in turn, phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2a), which then promotes translation of activating transcription factor 4 (ATF4) and subsequent induction of CHOP (C/EBP-homologous protein). 9 CHOP itself causes proapoptotic changes, such as downregulation of BCL-2 and activation of calcium signaling pathways with subsequent induction of FAS death receptor. 10 Robust evidence has accumulated from animal models of ApoE-deficient mice that activation of the PERK-CHOP branch of the unfolded protein response occurs in atherosclerotic lesions and promotes necrotic core formation. 11e15 Interestingly, only one study is available that has examined activation of the PERK-CHOP branch in a human specimen (coronary artery 16 ), but UPR-activation has not been studied so far in carotid plaques. Therefore, the aim of this study was to analyze activation of the PERK-CHOP branch of the UPR in human advanced rupture-prone carotid lesions.
METHODS

Carotid artery specimens
Carotid artery specimens were obtained from patients undergoing carotid endarterectomy for high-grade stenosis of the internal carotid artery at University Medical Center, Johannes-Gutenberg University, Mainz, Germany. The excised plaques were fixed in 4% formalin (Roth, Karlsruhe, Germany) immediately after retrieval in the operating room, and subsequently embedded in paraffin wax. The plaque cylinder was manually trimmed to an approximately 3 mm specimen containing the segment with maximum lumen reduction, which was subsequently cut into 3 mm transverse sections (perpendicular to the lumen), mounted on Superfrost Plus slides (Menzel, Thermo Scientific, Braunschweig, Germany) and deparaffinized in xylene. Carotid specimens were analyzed by histology and 10 specimens complying with criteria for rupture-prone plaques were chosen for further detailed analysis. Control specimens of common carotid artery and common femoral artery were obtained from patients without clinical evidence of atherosclerotic disease (vascular trauma, organ donor).
Clinical data were recorded for each patient. The use of human tissue for this study was approved by the local ethics committee and consent was obtained from the patients.
Histopathology
For morphological analysis, every 10th section was stained with hematoxylin and eosin (H&E, Gill's No.3, Polyscience Inc. Eppelheim, Germany) as well as Masson-Goldner (Roth). From those sets of 10 sections each, five sets containing the area of maximum lumen reduction were selected and five representative overviews of H&E staining of total plaque area of each cylinder were taken with a digital camera-equipped microscope (ZEISS Axioplan, Oberkochen, Olympus XC30, Hamburg, Germany). Cap thickness, area of the necrotic core and total area of the plaque were measured using CellSens Imaging Software (Olympus). The necrotic core was defined as amorphous material containing cholesterol crystals. The fibrous cap was identified, and the thinnest part (minimum cap thickness) and the part with a thickness considered to be most representative of the cap as a whole (representative cap thickness) were measured and averaged. 17 In addition, plaques were graded according to the AHA-classification. 18 Immunohistochemistry For each antibody, at least five representative sections of each specimen were stained. The sections were selected from the above described sets of 10 slides that allowed staining of the markers of apoptosis and UPR (n ¼ 8). Depending on additional stainings (double-immunohistochemistry) and for technical reasons, additional sets of 10 sections adjacent in both directions to the above described sets were used if needed. Thus, on average, representative sections stained for each plaque specimen covered a cylinder length of 300e450 mm. All antibodies used in this study are listed in Table 1 and were used according to the manufacturer's instructions and established protocols for detection of UPR-markers. 19, 20 Prior to blocking of endogenous peroxidase activity with 3% H 2 O 2 , antigen retrieval was performed for cleaved Caspase-3 and ATF-3 (activated transcription factor 3) by heating for 20 minutes at 95 C in citrate buffer (pH 6.0) in a waterbath, for CHAC-1 (cation transport regulator-like protein 1) with pre-digestion in ready-to-use proteinase K solution (DakoCytomation, Glostrup, Denmark) for 10 minutes, and for CHOP using Retrieve-All Antigen Unmasking System 2: Basic (pH 10) 1Â solution (Covance Research Products, USA) in a rice cooker (20 minutes, 95 C). After blocking with 10% goat normal serum, the slides were incubated with the primary antibody for 1 hour at room temperature, followed by a washing step and incubation with the appropriate HRP-conjugated secondary antibody (DakoCytomation) for 10 minutes. Reaction products were visualized by incubation in diaminobenzidine tetrachloride (brown color). Finally, the slides were counterstained with hematoxylin and mounted in Fluoromount aqueous mounting medium (Sigma-Aldrich, St. Louis, MO, USA) or in Entellan (Merck Millipore, Darmstadt, Germany). Irrelevant isotype-matched antibodies and control stainings omitting the primary antibody were used to exclude non-specific binding for each antibody, and human tonsil or pancreas were used as positive controls.
For staining analysis and semiquantitative analysis, one overview of total cross-sectional area (25Â magnification) and three representative high-power fields of the shoulder region (200Â magnification) were captured from each of the five sections with a digital camera equipped microscope (ZEISS Axioplan, Olympus XC30). Semiquantitative analysis of immunohistochemical stainings was performed by counting positively stained cells/nuclei in the high-power images by two independent researchers blinded for patient demographics using freely available ImageJ Software (http:// rsb.info.nih.gov/ij/disclaimer.html). 16 For CHAC1, staining was quantified as a positively stained area in at least three representative areas (plaque shoulder, magnification 200Â) of each of five representative sections using imaging software (CellSense, Olympus). Control values were obtained by quantifying areas of non-diseased internal carotid artery adjacent to the plaque for each specimen (n ¼ 10) as well as specimens of non-diseased common carotid (n ¼ 3) and common femoral (n ¼ 3) artery as described above.
Double-immunohistochemistry
For the simultaneous detection of two different antigens within the same specimen the EnVision Gj2 Doublestain System visualization kit (DakoCytomation) was used. The visualization is based on peroxidase (HRP) using DABþ as chromogen (brown color deposits, KDEL) and alkaline phosphatase (AP) using Permanent Red as chromogen (red color deposits, cCaspase-3/CD68/Actin) and were used according to the manufacturer's instructions. All antibodies used in this assay are detailed in Table 1 .
TUNEL-assay
For examining apoptosis by DNA fragmentation, the Apop-Tag Peroxidase In Situ Apoptosis Detection Kit (Millipore) was used according to the manufacturer's instructions. DNA strand breaks were detected by enzymatically labeling the free 3 0 -OH termini with modified nucleotides, and methyl green was used to counterstain nuclei.
Statistical analysis
Semiquantitative results were presented as indicated and testing of differences between values was performed using the ManneWhitney test (two-tailed). A p value of <.05 was considered statistically significant (*), a p value of <.001 was considered highly significant (***).
RESULTS
For this study, 10 specimens were selected and the respective patient characteristics were retrieved from the computerized database of the Division of Vascular Surgery of the University Medical Center ( Table 2 ). Analysis of lesion morphology confirmed that all specimens exhibited features of rupture-prone plaques corresponding to the inclusion criteria of this study. The average values for total representative cap thickness (all specimen) were 280 AE 60 mm and for total minimum cap thickness 129 AE 39 mm (Fig. 1A,B ), both being below the cut-off values of 500 mm and 200 mm, respectively. Selective analysis confirmed that each specimen had a representative cap thickness of less than 500 mm (Fig. 1A) , and all but one (#5) had a minimum cap thickness of less than 200 mm (Fig. 1B) . The size of the necrotic core was determined to be 44 AE 7% averaged for all specimens, and by selective analysis all specimens were again demonstrated to have a necrotic core size of at least 25% (Fig. 1C ). When criteria of the Stary-classification were applied, three specimens could be classified into Stary group IV (atheroma with necrotic core) and seven into Stary group VI (lesion with surface defect).
Immunohistochemistry was used to identify markers of apoptosis (cleaved Caspase-3 and TUNEL) and UPRactivation (KDEL, ATF3, CHOP, CHAC1) as well as cellular markers for macrophages (CD68). Fig. 2A shows a panel of representative stainings at low magnification to allow assessment of the whole circumferential cross-sectional area and spatial distribution of the individual stainings. In addition, Fig. 2A shows a representative H&E staining that was used for measurement of lesion morphology. It could be demonstrated that markers of apoptosis and UPRactivation showed increased expression in the shoulder region of the plaque and around the necrotic core. The appropriate sections of control tissues (common femoral artery, CFA, common carotid artery, CCA and internal carotid artery, ICA) as well as the negative and positive controls for each antibody used for semiquantitative analysis are depicted in Fig. 2B . For semiquantitative analysis, high-power magnifications were obtained from those regions and the individual markers were quantified. A highly significant increase of markers of apoptosis was found, that is TUNEL (1387 AE 66 cells/mm 2 ) and cleaved Caspase-3 (1923 AE 93 cells/mm 2 ) in the shoulder region of each plaque when compared with control sections (Fig. 3A,B ).
In addition, markers of UPR-activation were studied and, here, robust expression could be demonstrated for markers of the early UPR-signaling chain like Chaperons GRP 78 and 94 (summarized as KDEL, 1175 AE 40 cells/mm 2 ), ATF3 (1971 AE 69 cells/mm 2 ) as a central signaling molecule of the PERK-CHOP branch, and CHOP as the canonical pro-apoptotic UPR-effector (2173 AE 120 cells/mm 2 , Fig. 3Ce  E) . Again, expression of the above markers was found to be significantly increased when compared with control sections.
To provide additional evidence for the activation of CHOP, CHAC1 was studied, which has been reported to act as a downstream signaling molecule of CHOP. Here, it was found that CHAC1 is expressed in the shoulder region ( Fig. 4A ) and quantification revealed an expression rate of 27 AE 1%, which was highly significant when compared with control sections (Fig. 4B) .
Having shown that both markers of apoptosis and UPRactivation exhibited significantly increased expression in the plaques, a colocalization analysis was performed. When adjacent sections were stained for CHOP and TUNEL, both showed a matching staining pattern (Fig. 5A,B ) that was further corroborated by similar cell counts in semiquantitative analysis of positively stained cells (Fig. 5C ). To further corroborate those findings, doubleimmunohistochemistry was performed using antibodies for KDEL and cleaved Caspase-3. Again, simultaneous staining of cells with KDEL and cleaved Caspase-3 was demonstrated indicating presence of UPR-activation (ERstress) in apoptotic cells (Fig. 5D,E) . To further elucidate the cell type being involved, co-expression of UPR-marker KDEL with markers for smooth muscle cells and macrophages was analyzed. Using double-immunohistochemistry for KDEL and a-Actin/CD68, it was demonstrated that UPR-activation occurs only to a small extent in smooth muscle cell-rich areas (Fig. 5F ), but predominantly in macrophage-rich areas (Fig. 5G) .
When plaque apoptosis and UPR-activation were correlated with patient demographics, men showed a significant increase in plaque apoptosis (TUNEL, p ¼ .004) and UPRactivation (KDEL and CHOP: p < .0001, ATF3: p ¼ .09) when compared with women. There was no age difference between men and women (median age 74 vs. 72 years, range 62e81 vs. 68e84 years, 95% CI 65e82 vs. 66e81 years, p ¼ n.s.). Furthermore, patients on statin medication had a significant higher level of plaque apoptosis (TUNEL and cleaved Caspase-3, p < .001) when compared with patients not taking statins. Markers of UPR-activation, however, were not affected by statin medication (KDEL: p ¼ .85, AFT3: p ¼ .85, CHOP: p ¼ .25). For both factors (male gender and statin medication), parameters of plaque morphology (representative plaque thickness, minimum plaque thickness and size of necrotic core) were statistically similar compared with female gender (p ¼ .42, p ¼ .10 and p ¼ .42, respectively) and no statin medication (p ¼ .55, p ¼ .31 and p ¼ .31, respectively). With regards to clinical symptoms, a comparison of parameters for plaque morphology (representative and minimum cap thickness and size of necrotic core), lesional apoptosis (cleaved Caspase-3) and UPR-activation (KDEL, ATF3, CHOP) showed no significant difference between asymptomatic (n ¼ 3) and symptomatic (n 
DISCUSSION
Although the underlying pathomechanisms that govern plaque disruption in both the coronary and the carotid arteries share similarities, 21 different cut-off values have been described, which define the "rupture-prone" plaque. The Oxford plaque study found that critical cap thickness is greater in carotid plaques than in coronary plaques with a minimum cap thickness of less than 200 mm and a representative cap thickness of less than 500 mm. 17 A lipid core size of less than 25% of cross-sectional area was identified as one of the predominant histologic features in ruptured carotid plaques. 2 Consequently, for the present study the focus was on advanced carotid plaques and included only study specimen that fulfilled the three parameters of ruptured/ruptureprone carotid plaques (minimum cap thickness <200 mm, representative cap thickness <500 mm, necrotic core >25%). The majority (seven) of the specimens were complicated plaques (Stary VI) with surface fissure/rupture, the other three were advanced plaques (Stary IV), a ratio that has also been found in other studies examining culprit lesions. 22 In those specimens, a significant increase of apoptosis as a key-stone element of plaque progression towards rupture could be demonstrated by immunohistochemical detection of cleaved Caspase-3 and DNA strand breaks (TUNEL) in comparison with control specimens. For evaluation of activation of the UPR, the focus was on three wellestablished signaling molecules involved in the proapoptotic PERK-CHOP branch: Chaperones GRP78 and GRP94 (recognized by the c-terminal retention sequence KDEL 11, 16, 19 ), ATF3 20,23,24 and CHOP. 7, 14, 16, 19 Using semiquantitative analysis of immunohistochemical detection of KDEL, ATF3 and CHOP, it was shown that expression of all three signaling molecules is robust and significantly increased in plaques when compared with control tissue (common femoral, common carotid, and non-diseased internal carotid artery).
Those findings are in line with results obtained from an analysis of 16 human coronary atherectomy specimens of patients where a significant increase in KDEL-and CHOP-positive cells in patients with unstable angina versus stable angina was documented. 16 In addition to the work of Myoishi et al., which so far is the only available study on human tissue, convincing evidence from genetically modified atherogenic mouse models (ApoEÀ/À) exists wherein a significant increase in the expression of KDEL and CHOP in lesions could be documented. 11, 15 Vice versa, by using a combined CHOPÀ/À ApoEÀ/À deficient mouse model, a significant reduction of UPR-activation (GRP78) and plaque size, 12 as well as a significant reduction of lesional apoptosis (TUNEL-positive cells) was shown. 13, 14 To corroborate the above findings of UPR-activation, additive evidence of increased CHOP expression was evaluated, that is the key element of the proapoptotic UPRbranch, CHAC-1 (cation transport regulator-like protein 1), has been identified to act as a proapoptotic component of the UPR downstream of CHOP. 20, 23, 24 It was shown that CHAC1 expression is significantly increased in plaques when compared with control tissue.
Colocalization analysis confirmed that markers of UPRactivation and apoptosis can be detected in close proximity at the cellular level, and it was shown that UPRactivation can be predominantly localized in lesional macrophages and, to a lesser extent, smooth muscle, which again is in line with findings obtained by other groups. 14e16 In addition, analysis of plaque apoptosis revealed a significant effect of statin therapy and supports findings of apoptosis induction in vascular cells by HMG-CoA reductase inhibitors. 25 A potential influence of gender was also seen in this study, with increased apoptosis and UPR-activation in male patients that may be attributed to increased susceptibility of men to inflammatory processes. However, the mean age in this study was 73 years and the role of gender differences related to postmenopausal hormone changes (estrogen) remains controversial. 26 Taken together, specimens were selected in this study that fulfilled morphologic criteria of rupture-prone carotid plaques and it was shown that activation of the proapoptotic CHOP-branch of the UPR occurs in lesional macrophages, and to a lesser extent smooth muscle cells, and colocalizes with markers of apoptosis. To the authors' knowledge, this is the first study examining UPR-activation in human carotid plaques and the findings fit well with results obtained from human coronary plaques and data from atherogenic mice models highlighting ER-stress and the UPR as a potential and potent inducer of apoptosis of vascular cells and thereby contributing to plaque progression and rupture.
Potential limitations of this study include the lack of multivariate regression analysis to identify potential influences on apoptosis and UPR-activation related to the number of specimens analyzed. Furthermore, in this pilot study, a correlation was performed between plaque morphology and individual clinical status (symptomatic vs. asymptomatic), which yielded no significant difference between the groups. Of note, the actual number of specimens in the asymptomatic group was low (n ¼ 3) and there are controversial reports on the validity of such a correlation. 22, 27 Furthermore, the current clinical definition of a "symptomatic" carotid stenosis covers a wide time interval of up to 6 months after the onset of neurological symptoms. In the present study, "symptomatic" specimens showed a considerable variation in time from insult to operation, of between 1 and 35 days. However, it is realized that correlation of clinical status with UPR-activation in a study enrolling a larger specimen series of both asymptomatic and symptomatic stenoses with short interval from onset of symptoms to operation (<7 days), may provide additional insight and should be addressed in a future study. Thirdly, owing to the indication for operative endarterectomy (high-grade stenosis), it was not possible to include a control group of early stages of plaque development (moderate stenosis). Therefore, there is the possibility that the activation of apoptosis and UPR observed under the study conditions may also be a response to plaque remodeling rather than an actual cause of plaque rupture.
Putting the results into perspective, acute cerebrovascular events (stroke and TIA) may now be considered as the clinical events together with acute coronary syndromes that warrant intense research into development and implementation of anti-apoptotic strategies. Targeting activation of the UPR-PERK/CHOP-branch specifically may serve as a potential mechanism to relieve ER-induced apoptosis, and thereby reduce acute events/plaque ruptures in cardiovascular disease. However, because of the complexity of the UPRsignaling network and its fundamental role in cellular homeostasis (protein synthesis) and survival, further work is needed to understand the interplay of the UPR effectors and dissect elements with the most promising therapeutic gain.
